BriaCell Therapeutics (BCTX) Short Interest Ratio & Short Volume → The #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique Way (From Smallcaps Daily) (Ad) Free BCTX Stock Alerts $1.55 -0.08 (-4.91%) (As of 09:52 AM ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media BriaCell Therapeutics Short Interest DataCurrent Short Volume667,700 sharesPrevious Short Volume685,000 sharesChange Vs. Previous Month-2.53%Dollar Volume Sold Short$1.45 millionShort Interest Ratio / Days to Cover8.9Last Record DateApril 30, 2024Outstanding Shares15,980,000 sharesFloat Size14,040,000 sharesShort Percent of Float4.76%Today's Trading Volume47,696 sharesAverage Trading Volume82,266 sharesToday's Volume Vs. Average58% Short Selling BriaCell Therapeutics ? Sign up to receive the latest short interest report for BriaCell Therapeutics and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatBCTX Short Interest Over TimeBCTX Days to Cover Over TimeBCTX Percentage of Float Shorted Over Time Ad Smallcaps DailyThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WayNanoviricides Technology Will Transform The Way Viruses & Their Variants Are Treated Worldwide And This Company Is At The Forefront!See how with its ongoing expansion and development BriaCell Therapeutics Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 4/30/2024667,700 shares $1.45 million -2.5%4.8%8.9 $2.17 4/15/2024685,000 shares $1.59 million +1.1%4.9%8.1 $2.32 3/31/2024677,900 shares $1.94 million -7.6%4.8%7.2 $2.86 3/15/2024733,300 shares $2.16 million -7.9%5.2%6.8 $2.95 2/29/2024795,900 shares $2.75 million -2.8%5.7%7.7 $3.46 2/15/2024818,800 shares $2.64 million -6.1%5.8%8.3 $3.23 Get the Latest News and Ratings for BCTX and Related StocksEnter your email address below to receive the latest news and analysts' ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 1/31/2024871,900 shares $3.59 million +1.0%6.2%9.2 $4.12 1/15/2024863,700 shares $3.79 million +0.6%6.2%7.6 $4.39 12/31/2023858,500 shares $5.02 million +1.6%6.1%8 $5.85 12/15/2023845,200 shares $3.49 million -11.2%6.0%8.8 $4.13 11/30/2023951,900 shares $5.04 million -2.8%6.8%10.5 $5.29 11/15/2023979,100 shares $4.31 million +3.8%7.0%10 $4.40 10/31/2023943,400 shares $4.01 million -7.5%7.1%9.2 $4.25 10/15/20231,020,000 shares $5.00 million -2.9%7.7%12 $4.90 9/30/20231,050,000 shares $6.56 million -3.7%8.0%12.5 $6.25 9/15/20231,090,000 shares $6.63 million -3.5%8.3%11.8 $6.08 8/31/20231,130,000 shares $8.12 million +3.7%8.6%11.9 $7.19 8/15/20231,090,000 shares $7.54 million +3.8%8.3%11.8 $6.92 7/31/20231,050,000 shares $7.02 million +1.0%8.0%10 $6.69 7/15/20231,040,000 shares $6.71 million -1.0%9.1%9.4 $6.45 6/30/20231,050,000 shares $6.74 million -4.6%9.2%8.4 $6.42 6/15/20231,100,000 shares $6.67 million -12.7%9.7%8.8 $6.06 5/31/20231,260,000 shares $7.47 million -6.0%11.4%9.9 $5.93 5/15/20231,340,000 shares $8.80 million -3.6%12.2%9.6 $6.57 4/30/20231,390,000 shares $10.34 million -4.1%12.6%9.1 $7.44 4/15/20231,450,000 shares $10.44 million +1.4%13.2%8.6 $7.20 3/31/20231,430,000 shares $10.65 million -4.7%13.9%7.6 $7.45 3/15/20231,500,000 shares $10.50 million -6.3%14.6%7.1 $7.00 2/28/20231,600,000 shares $11.33 million +4.6%15.5%7.2 $7.08 2/15/20231,530,000 shares $12.22 million +1.3%14.9%6.7 $7.99 1/31/20231,510,000 shares $11.29 million +15.3%14.7%6.7 $7.48 1/15/20231,310,000 shares $8.71 million -0.8%12.6%5.1 $6.65 12/30/20221,320,000 shares $5.77 million -5.7%12.7%5.6 $4.37 12/15/20221,400,000 shares $7.87 million No Change13.5%5.6 $5.62 11/30/20221,400,000 shares $7.52 million No Change13.5%4.1 $5.37 11/15/20221,400,000 shares $7.69 million +12.9%13.5%3.8 $5.49 10/31/20221,240,000 shares $6.82 million -10.1%11.9%3.2 $5.50 10/15/20221,380,000 shares $9.12 million +3.8%13.3%3.4 $6.61 9/30/20221,330,000 shares $7.47 million -16.9%12.8%3.4 $5.62 9/15/20221,600,000 shares $12.91 million +2.6%15.4%3.9 $8.07Democrats Push to Replace Dollar With Digital Coin, Control Currency. (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. BCTX Short Interest - Frequently Asked Questions What is BriaCell Therapeutics' current short interest? Short interest is the volume of BriaCell Therapeutics shares that have been sold short but have not yet been closed out or covered. As of April 30th, investors have sold 667,700 shares of BCTX short. 4.76% of BriaCell Therapeutics' shares are currently sold short. Learn More on BriaCell Therapeutics' current short interest. What is a good short interest ratio for BriaCell Therapeutics? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. BCTX shares currently have a short interest ratio of 9.0. Learn More on BriaCell Therapeutics's short interest ratio. Which institutional investors are shorting BriaCell Therapeutics? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of BriaCell Therapeutics: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for BriaCell Therapeutics? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 4.76% of BriaCell Therapeutics' floating shares are currently sold short. Is BriaCell Therapeutics' short interest increasing or decreasing? BriaCell Therapeutics saw a decline in short interest in the month of April. As of April 30th, there was short interest totaling 667,700 shares, a decline of 2.5% from the previous total of 685,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is BriaCell Therapeutics' float size? BriaCell Therapeutics currently has issued a total of 15,980,000 shares. Some of BriaCell Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. BriaCell Therapeutics currently has a public float of 14,040,000 shares. How does BriaCell Therapeutics' short interest compare to its competitors? 4.76% of BriaCell Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical preparations" compare to BriaCell Therapeutics: NRx Pharmaceuticals, Inc. (6.36%), Fortress Biotech, Inc. (12.69%), Spruce Biosciences, Inc. (0.97%), Acurx Pharmaceuticals, Inc. (4.67%), Aprea Therapeutics, Inc. (1.90%), Apollomics, Inc. (0.19%), Daré Bioscience, Inc. (0.29%), ImmunoPrecise Antibodies Ltd. (1.45%), Viracta Therapeutics, Inc. (2.54%), Marker Therapeutics, Inc. (0.84%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks. What does it mean to sell short BriaCell Therapeutics stock? Short selling BCTX is an investing strategy that aims to generate trading profit from BriaCell Therapeutics as its price is falling. BCTX shares are trading down $0.43 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against BriaCell Therapeutics? A short squeeze for BriaCell Therapeutics occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of BCTX, which in turn drives the price of the stock up even further. How often is BriaCell Therapeutics' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including BCTX, twice per month. The most recent reporting period available is April, 30 2024. More Short Interest Resources from MarketBeat Related Companies: NRx Pharmaceuticals Short Interest Fortress Biotech Short Interest Spruce Biosciences Short Interest Acurx Pharmaceuticals Short Interest Aprea Therapeutics Short Interest Apollomics Short Interest Daré Bioscience Short Interest ImmunoPrecise Antibodies Short Interest Viracta Therapeutics Short Interest Marker Therapeutics Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:BCTX) was last updated on 5/16/2024 by MarketBeat.com Staff From Our PartnersThe #1 Biotech Stock to Watch in 2024 is Attacking Viruses in a Unique WaySmallcaps DailyWATCH: The Truth About InflationBirch GoldRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTop 5 AI Stocks to Buy for 2024Market Moving TrendsTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeDoes this make you sick?Allegiance Gold